| H-Pro-His-Gly-OH | C13H19N5O4 | 309.33 | 83960-30-9 | H-Pro-His-Gly-OH |
| (Cys(Acm)33)-Endostatin (6-49) (human) | C215H336N64O56S2 | 4777.56 | H-Phe-Gln-Pro-Val-Leu-His-Leu-Val-Ala-Leu-Asn-Ser-Pro-Leu-Ser-Gly-Gly-Met-Arg-Gly-Ile-Arg-Gly-Ala-Asp-Phe-Gln-Cys(Acm)-Phe-Gln-Gln-Ala-Arg-Ala-Val-Gly-Leu-Ala-Gly-Thr-Phe-Arg-Ala-Phe-OH | |
| TIMP-2 (145-168) (human, bovine), metalloproteinase Inhibitor 2 (145-168) (human, bovine) | C131H189N33O35S3 | 2882.34 | H-Glu-Cys-Leu-Trp-Met-Asp-Trp-Val-Thr-Glu-Lys-Asn-Ile-Asn-Gly-His-Gln-Ala-Lys-Phe-Phe-Ala-Cys-Ile-OH (Disulfide bond) | |
| E-76 | C97H139N27O29S2 | 2211.47 | Ac-Ala-Leu-Cys-Asp-Asp-Pro-Arg-Val-Asp-Arg-Trp-Tyr-Cys-Gln-Phe-Val-Glu-Gly-NH2 (Disulfide bond) | |
| Activated Protein C (390-404) (human), APC (390-404) (human) | C91H130N22O23 | 1900.17 | 146340-20-7 | H-Tyr-Gly-Val-Tyr-Thr-Lys-Val-Ser-Arg-Tyr-Leu-Asp-Trp-Ile-His-OH |
| (D-Arg32)-Antistasin (32-38), Antistasin-Related Peptide | C34H57N15O8S2 | 868.05 | H-D-Arg-Cys-Arg-Val-His-Cys-Pro-OH (Disulfide bond) | |
| Fibrinogen-Binding Peptide | C25H39N7O8 | 565.63 | 137235-80-4 | H-Glu-His-Ile-Pro-Ala-OH |
| (Cys39)-Tissue Factor (33-53) | C111H166N26O33S2 | 2456.83 | 313642-01-2 | H-Val-Tyr-Thr-Val-Gln-Ile-Cys-Thr-Lys-Ser-Gly-Asp-Trp-Lys-Ser-Lys-Cys-Phe-Tyr-Thr-Thr-OH (Disulfide bond) |
| H-Ala-Trp-OH | C14H17N3O3 | 275.31 | 16305-75-2 | H-Ala-Trp-OH |
| H-Ala-Tyr-OH | C12H16N2O4 | 252.27 | 3061-88-9 | H-Ala-Tyr-OH |
| H-Gly-Gly-Tyr-OH | C13H17N3O5 | 295.3 | 17343-07-6 | H-Gly-Gly-Tyr-OH |
| H-Ile-Arg-Pro-OH | C17H32N6O4 | 384.48 | H-Ile-Arg-Pro-OH | |
| H-Ile-Pro-Pro-OH | C16H27N3O4 | 325.41 | 26001-32-1 | H-Ile-Pro-Pro-OH |
| H-Ile-Trp-OH | C17H23N3O3 | 317.39 | 13589-06-5 | H-Ile-Trp-OH |
| H-Ile-Tyr-OH | C15H22N2O4 | 294.35 | 38579-21-4 | H-Ile-Tyr-OH |
| H-Leu-Ala-Pro-OH | C14H25N3O4 | 299.37 | 132548-09-5 | H-Leu-Ala-Pro-OH |
| H-Leu-Arg-Pro-OH | C17H32N6O4 | 384.48 | 133943-59-6 | H-Leu-Arg-Pro-OH |
| H-Leu-Gly-Pro-OH | C13H23N3O4 | 285.34 | H-Leu-Gly-Pro-OH | |
| H-Leu-Pro-Pro-OH | C16H27N3O4 | 325.41 | 121305-26-8 | H-Leu-Pro-Pro-OH |
| H-Leu-Trp-OH | C17H23N3O3 | 317.39 | 5156-22-9 | H-Leu-Trp-OH |
| H-Met-Trp-OH | C16H21N3O3S | 335.43 | 60535-02-6 | H-Met-Trp-OH |
| H-Pro-Arg-OH | C11H21N5O3 | 271.32 | 2418-74-8 | H-Pro-Arg-OH |
| H-Tyr-Leu-OH | C15H22N2O4 | 294.35 | 17355-10-1 | H-Tyr-Leu-OH |
| H-Val-Phe-OH | C14H20N2O3 | 264.32 | 3918-92-1 | H-Val-Phe-OH |
| H-Val-Pro-Pro-OH | C15H25N3O4 | 311.38 | 58872-39-2 | H-Val-Pro-Pro-OH |
| H-D-Val-Pro-Pro-OH | C15H25N3O4 | 311.38 | H-D-Val-Pro-Pro-OH | |
| H-Val-D-Pro-Pro-OH | C15H25N3O4 | 311.38 | H-Val-D-Pro-Pro-OH | |
| H-Val-Tyr-OH | C14H20N2O4 | 280.32 | 3061-91-4 | H-Val-Tyr-OH |
| H-Val-Tyr-Pro-OH | C19H27N3O5 | 377.44 | 68076-97-1 | H-Val-Tyr-Pro-OH |
| IDR-1, Innate Defense-Regulator Peptide | C65H118N18O15 | 1391.76 | 940291-10-1 | H-Lys-Ser-Arg-Ile-Val-Pro-Ala-Ile-Pro-Val-Ser-Leu-Leu-NH2 |
| Acetyl-Adhesin (1025-1044) amide | C97H160N26O32 | 2202.49 | 320350-56-9 | Ac-Gln-Leu-Lys-Thr-Ala-Asp-Leu-Pro-Ala-Gly-Arg-Asp-Glu-Thr-Thr-Ser-Phe-Val-Leu-Val-NH2 |
| Bactenecin | C63H118N24O13S2 | 1483.92 | 116229-36-8 | H-Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg-OH (Disulfide bond) |
| Beauvericin | C45H57N3O9 | 783.96 | 26048-05-5 | Cyclo(-D-α-hydroxyisovaleryl-N-Me-Phe)3 |
| Bombinin-Like Peptide, BLP-1 | C115H194N34O33 | 2581.02 | 138220-00-5 | H-Gly-Ile-Gly-Ala-Ser-Ile-Leu-Ser-Ala-Gly-Lys-Ser-Ala-Leu-Lys-Gly-Leu-Ala-Lys-Gly-Leu-Ala-Glu-His-Phe-Ala-Asn-NH2 |
| Brevinin-1 | C121H202N28O26S2 | 2529.24 | 145963-49-1 | H-Phe-Leu-Pro-Val-Leu-Ala-Gly-Ile-Ala-Ala-Lys-Val-Val-Pro-Ala-Leu-Phe-Cys-Lys-Ile-Thr-Lys-Lys-Cys-OH (Disulfide bond) |
| Dermaseptin | C152H257N43O44S2 | 3455.11 | 136033-70-0 | H-Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Ala-Leu-Gly-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln-OH |
| Dermcidin-1L (human), DCD-1L (human) | C210H359N57O71 | 4818.5 | H-Ser-Ser-Leu-Leu-Glu-Lys-Gly-Leu-Asp-Gly-Ala-Lys-Lys-Ala-Val-Gly-Gly-Leu-Gly-Lys-Leu-Gly-Lys-Asp-Ala-Val-Glu-Asp-Leu-Glu-Ser-Val-Gly-Lys-Gly-Ala-Val-His-Asp-Val-Lys-Asp-Val-Leu-Asp-Ser-Val-Leu-OH | |
| Epinecidin-1 | C114H176N30O21S | 2334.91 | 1131706-77-8 | H-Gly-Phe-Ile-Phe-His-Ile-Ile-Lys-Gly-Leu-Phe-His-Ala-Gly-Lys-Met-Ile-His-Gly-Leu-Val-NH2 |
| Extracellular Death Factor, EDF | C27H36N10O10 | 660.64 | 960129-66-2 | H-Asn-Asn-Trp-Asn-Asn-OH |
| Hecate, Hecate-1 | C123H226N32O24 | 2537.35 | 133084-63-6 | H-Phe-Ala-Leu-Ala-Leu-Lys-Ala-Leu-Lys-Lys-Ala-Leu-Lys-Lys-Leu-Lys-Lys-Ala-Leu-Lys-Lys-Ala-Leu-OH |
| Indolicidin | C100H132N26O13 | 1906.32 | 140896-21-5 | H-Ile-Leu-Pro-Trp-Lys-Trp-Pro-Trp-Trp-Pro-Trp-Arg-Arg-NH2 |
| Parasin I | C82H154N34O24 | 2000.34 | 219552-69-9 | H-Lys-Gly-Arg-Gly-Lys-Gln-Gly-Gly-Lys-Val-Arg-Ala-Lys-Ala-Lys-Thr-Arg-Ser-Ser-OH |
| Ranalexin | C97H167N23O22S3 | 2103.73 | 155761-99-2 | H-Phe-Leu-Gly-Gly-Leu-Ile-Lys-Ile-Val-Pro-Ala-Met-Ile-Cys-Ala-Val-Thr-Lys-Lys-Cys-OH (Disulfide bond) |
| Sapecin | C164H266N58O52S6 | 4074.67 | 119938-54-4 | H-Ala-Thr-Cys-Asp-Leu-Leu-Ser-Gly-Thr-Gly-Ile-Asn-His-Ser-Ala-Cys-Ala-Ala-His-Cys-Leu-Leu-Arg-Gly-Asn-Arg-Gly-Gly-Tyr-Cys-Asn-Gly-Lys-Ala-Val-Cys-Val-Cys-Arg-Asn-OH (Disulfide bonds between Cys³ and Cys³⁰/Cys¹⁶ and Cys³⁶/Cys²⁰ and Cys³⁸) |
| Seminalplasmin Fragment (SPF) Analog, SPFK | C76H123N17O16 | 1530.92 | 147958-06-3 | H-Pro-Lys-Leu-Leu-Lys-Thr-Phe-Leu-Ser-Lys-Trp-Ile-Gly-OH |
| Tritrpticin | C96H132N28O14 | 1902.28 | 179264-81-4 | H-Val-Arg-Arg-Phe-Pro-Trp-Trp-Trp-Pro-Phe-Leu-Arg-Arg-OH |
| RIP | C45H55N9O12 | 913.99 | 228544-21-6 | H-Tyr-Ser-Pro-Trp-Thr-Asn-Phe-OH |
| H-Gly-Pro-Gly-NH2 | C9H16N4O3 | 264.71 | 141497-12-3 | H-Gly-Pro-Gly-NH2 · HCl |
| Fusion Inhibitory Peptide, FIP, Virus Replication Inhibitory Peptide | C28H29N3O6 | 503.56 | 75539-79-6 | Z-D-Phe-Phe-Gly-OH |
| H(-Arg-εAhx)6-Arg-OH | C78H152N34O14 | 1790.29 | 457633-17-9 | H-Arg-ε-aminocaproyl-Arg-ε-aminocaproyl-Arg-ε-aminocaproyl-Arg-ε-aminocaproyl-Arg-ε-aminocaproyl-Arg-ε-aminocaproyl-Arg-OH |
